Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bretley Sitzman

Pain Medicine Hattiesburg, MS Medical Doctor

NPI 1295845311 CMS profile 240621

7125 U S Highway 98, Hattiesburg, MS 39402

Open in the dashboard

General payments

$17,925

136 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bretley Sitzman of Hattiesburg, MS is reported in the CMS Open Payments database as having received $17,925 across 136 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $180 3
2024 General $174 2
2023 General $105 3
2022 General $197 9
2021 General $169 11
2020 General $6,824 31
2019 General $10,276 77

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bretley Sitzman
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Bretley Sitzman were reported at $180. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Bretley Sitzman Pain Medicine median Middle half National median
2019 $10,276 $498 $126–$1,682 $163
2020 $6,824 $284 $80–$910 $114
2021 $169 $399 $112–$1,219 $132
2022 $197 $455 $137–$1,484 $149
2023 $105 $484 $128–$1,495 $160
2024 $174 $498 $131–$1,540 $164
2025 $180 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pfizer Inc. $9,957 26 payments
  2. Lilly USA, LLC $3,600 1 payment
  3. Vertiflex, Inc. $1,226 8 payments
  4. Medtronic USA, Inc. $1,109 22 payments
  5. Nevro Corp. $403 21 payments
  6. Stimwave Technologies Incorporated $220 2 payments
  7. Stryker Corporation $174 2 payments
  8. Biodelivery Sciences International, Inc. $174 11 payments
  9. Medtronic, Inc. $150 5 payments
  10. Boston Scientific Corporation $131 5 payments
  11. Other $779 33 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $10,620 2 payments
  2. Food and Beverage $3,444 129 payments
  3. Honoraria $2,750 1 payment
  4. Travel and Lodging $1,111 4 payments
Products named General payments · program years 2019–2025
  1. Superion ISS $1,226 8 payments
  2. INTELLIS $1,039 21 payments
  3. Senza Spinal Cord Stimulation System $345 17 payments
  4. SPINEJACK $174 2 payments
  5. BELBUCA $146 9 payments
  6. INTELLIS ADAPTIVESTIM $132 4 payments
  7. XTAMPZA $128 8 payments
  8. Eon Family of SCS IPGs $120 1 payment
  9. Zilretta $112 6 payments
  10. LYRICA $104 13 payments
  11. Other $759 54 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 46 drugs

Part D claims

4,353

Median for Anesthesiology: 322

Drug cost

$231,867

Median for Anesthesiology: $8,738

Branded share of claims

35.9%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xtampza Er Oxycodone Myristate Brand 53 $61,829
Fentanyl Generic 318 $52,058
Oxycontin Oxycodone Hcl Brand 27 $27,003
Morphine Sulfate Er Morphine Sulfate Brand 517 $16,390
Linzess Linaclotide Brand 27 $13,286
Hysingla Er Hydrocodone Bitartrate Brand 13 $12,595
Oxycodone Hcl Generic 476 $10,334
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 545 $9,420
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 286 $7,802
Gabapentin Generic 397 $4,992

The 10 drugs with the highest cost, of 46 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Records

136 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record